ValGenesis Launches the Next Generation of VAL™, Bringing Governed AI to the Validation Lifecycle ValGenesis, the market leader in digital validation lifecycle management, announced the launch of the next generation of VAL™ (ValGenesis AI), designed to help life sciences companies…
Nick Dokoozlian Named Recipient of Triple Helix AgTech Leadership Prize Triple Helix Institute for Agriculture, Climate, and Society a nonprofit dedicated to building cross-sector engagement and public understanding around agriculture technology (AgTech), today announced Dr. Nick Dokoozlian as the recipient…
Promega Expands Forensic Portfolio with Distribution Agreement for NimaGen’s IDseek® MPS Library Prep Kits Forensic casework laboratories will now have access to NimaGen’s IDseek® massively parallel sequencing (MPS) kit portfolio through Promega Corporation, following a distribution agreement announced today between the two…
Valo Health Appoints Chris Anagnostopoulos, PhD, as Chief Causal AI Officer Valo Health, Inc. a pioneer in the use of human data and AI to accelerate drug discovery and development, announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the…
Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training Compass Pathways plc a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced an invitation for U.S. based organizations to apply…
Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients…
Genialis Supermodel Predicts Patient Response to HER2-Targeted Therapy Enhertu Genialis, the therapeutic intelligence company, announced it will present the first results from a new AI-based algorithm designed to distinguish between patients more likely to benefit from treatment with trastuzumab deruxtecan (Enhertu®, T-DXd).…
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance…
Quiver Bioscience Receives Strategic Investment From the Porta Family to Advance UBE3A ASO Therapeutic Program for Dup15q Syndrome Quiver Bioscience a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, today announced…
Transcat Expands into Latin America with Acquisition of SCM Metrology and Laboratories S.A. Transcat, Inc. a leading provider of test measurement, control and calibration, announced the acquisition of SCM Metrology and Laboratories S.A. (“SCM”), a privately-held calibration services provider based…
Emalex Receives U.S. Patent for Orally Disintegrating Ecopipam Formulation Emalex Biosciences announced that the U.S. Patent and Trademark Office issued a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 receptor antagonist in development for the…
ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces today the appointment of Christoph Korpus, PhD, MBA, as Chief Executive Officer (CEO), effective…